NanoViricides Announces That Clinical Trials Of A Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun

Benzinga 2023-07-05

Views 1

NanoViricides $NNVC is a drug development company working on a novel nanomedical treatment. It recently updated the world on the status of its long-awaited and now active trials into its lead drug candidate, NV-CoV-2

Share This Video


Download

  
Report form
RELATED VIDEOS